Cortex' CX717 Released from Clinical Hold by FDA IRVINE, Calif.--Oct. 9, 2006--Cortex Pharmaceuticals, Inc.(AMEX:COR) received notification from the U.S. Food and DrugAdministration (FDA) on the afternoon of Friday, October 6, 2006 thatthe clinical hold placed on its AMPAKINE(R) CX717 on March 31, 2006was lifted. The Company may now resume the clinical trials that wereunderway at the time the ...


